Clinical Trial Update: Mechanisms of Lorcaserin for Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial update on lorcaserin mechanisms for smoking cessation has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation
• Tobacco Use Disorder

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: The Mind Research Network | Conditions: Tobacco Use Disorder, Smoking Cessation | Phase 2 | Status: TERMINATED | Results posted: 2023-03-20